LUNG vs OM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

LUNG

33.4
AI Score
VS
OM Wins

OM

38.9
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
SELL

OM

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG OM Winner
Revenue 93.09M 66.18M OM
Net Income -51.65M -32.13M LUNG
Gross Margin 41.9% 77.3% LUNG
Net Margin -55.5% -48.5% LUNG
Operating Income -44.86M -29.50M LUNG
ROE -62.0% -93.9% OM
ROA -22.4% -29.2% OM
Total Assets 230.41M 110.21M OM
Cash 33.94M 52.69M LUNG
Debt/Equity 1.18 1.11 LUNG
Current Ratio 4.86 4.05 OM
Free Cash Flow -33.14M -18.51M LUNG

Relative Price Performance (Last 90 Days)

LUNG 1M: +55.6% · 3M: +22.3% OM 1M: +5.2% · 3M: -6.2%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62

RSI (14): 62.5 · Price: $2.80

OM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.2 · Price: $4.22

Fundamentals Snapshot

Metric LUNG OM
Market Cap — —
Forward P/E -3.1 -1.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.4%
Operating Margin -0.3% -0.5%
EPS -1.01 -3.78
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.